First trimester termination of pregnancy

被引:14
作者
Lui, Man-Wa [1 ]
Ho, Pak-Chung [1 ]
机构
[1] Univ Hong Kong, Dept Obstet & Gynaecol, Queen Mary Hosp, 6-F Professorial Block,102 Pokfulam Rd, Hong Kong, Peoples R China
关键词
First trimester; Termination of pregnancy; Vacuum aspiration; Misoprostol; Mifepristone; EARLY MEDICAL ABORTION; RANDOMIZED CONTROLLED-TRIAL; ELECTRIC VACUUM ASPIRATION; CERVICAL-DILATION; SURGICAL ABORTION; MIFEPRISTONE-MISOPROSTOL; 1ST-TRIMESTER ABORTION; PARACERVICAL-BLOCK; INTERVALS; EFFICACY;
D O I
10.1016/j.bpobgyn.2019.06.004
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
First trimester termination of pregnancy (TOP) is a safe and effective procedure. The complete abortion rates of surgical and medical abortion are approximately 97% and 95%, respectively. Vacuum aspiration (VA) either by electrical suction or manual aspiration is the method of choice for surgical TOP. Risk of significant bleeding is <= 5% in VA, while major complications occur in <1%. The risk of infection after VA can be reduced significantly by using prophylactic antibiotics or by the screen-and-treat strategy. Pre-operative administration of misoprostol can also reduce the risk of complications. The combination of 200 mg mifepristone followed by 800 mu g misoprostol 24-48 h later is recommended for first trimester medical TOP. If mifepristone is not available, misoprostol can also be used alone, but repeated doses may be required and the complete abortion rate may be lower. Due to the reduced efficacy in more advanced gestation, repeated doses of misoprostol may be required for medical TOP over 9 weeks of gestation. The complete abortion rate with this regimen is 95% or more. Gastrointestinal upsets can occur in up to 50% of women, but major complications are rare. There was no lower limit of gestational week for TOP, although extra precaution is required for the confirmation of completion of procedures and exclusion of ectopic pregnancy. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 70 条
  • [1] Cervical dilation before first-trimester surgical abortion (&lt;14 weeks' gestation)
    Allen, Rebecca H.
    Goldberg, Alisa B.
    [J]. CONTRACEPTION, 2016, 93 (04) : 277 - 291
  • [2] [Anonymous], 2014, Obstet Gynecol, V123, P676, DOI 10.1097/01.AOG.0000444454.67279.7d
  • [3] [Anonymous], BROCHURE
  • [4] [Anonymous], 2011, CAR WOM REQ IND AB E
  • [5] [Anonymous], 2011, COCHRANE DATABASE SY
  • [6] Adult Brainstem Glioblastoma Multiforme: Long-term Survivor
    Barnard, Zachary R.
    Drazin, Doniel
    Bannykh, Serguei I.
    Rudnick, Jeremy D.
    Chu, Ray M.
    [J]. CUREUS, 2015, 7 (12):
  • [7] Evaluation of effect of letrozole prior to misoprostol in comparison with misoprostol alone in success rate of induced abortion
    Behroozi-Lak, T.
    Derakhshan-Aydenloo, S.
    Broomand, F.
    [J]. JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION, 2018, 47 (03) : 113 - 117
  • [8] Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam
    Blum, Jennifer
    Raghavan, Sheila
    Dabash, Rasha
    Nguyen Thi Nhu Ngoc
    Chelli, Hela
    Hajri, Selma
    Conkling, Kathryn
    Winikoff, Beverly
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2012, 118 (02) : 166 - 171
  • [9] Mifepristone followed in 24 hours to 48 hours by misoprostol for late first-trimester abortion
    Bracken, Hillary
    Ngoc, Nguyen Thi Nhu
    Schaff, Eric
    Coyaji, Kurus
    Ambardekar, Shubha
    Westheimer, Emily
    Winikoff, Beverly
    [J]. OBSTETRICS AND GYNECOLOGY, 2007, 109 (04) : 895 - 901
  • [10] Induced abortion
    Cameron, S.
    Glasier, A.
    Lohr, P. A.
    Moreau, C.
    Munk-Olssen, T.
    Oppengaard, K. S.
    Templeton, A.
    Van Look, P.
    Baird, D. T.
    Crosignani, P. G.
    La Vecchia, C.
    Negri, E.
    Volpe, A.
    [J]. HUMAN REPRODUCTION, 2017, 32 (06) : 1160 - 1169